Denmark· DK-28105798716
Brineura
A cerliponase alfa product containing cerliponase alfa, registered in Denmark by BioMarin International Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Cerliponase alfa is registered in 10 of 19 countries.
Countries holding a registration under ATC A16AB17 (cerliponase alfa), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Cerliponase alfa · ATC A16AB17
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Cerliponase alfa
- Manufacturer
- BioMarin International Limited
- Country
- Denmark (DK)
- ATC code
- A16AB17
- ATC class
- Cerliponase alfa
- Defined daily dose
- 21 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105798716
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A16AB17
Cerliponase alfa, as other registers publish it.
- IcelandBrineuraBioMarin International Limited
- FinlandBrineuraBiomarin International Limited
- PolandBrineuraBioMarin International Ltd.
- CzechiaBRINEURABioMarin International Limited, Dublin
- CanadaBRINEURABIOMARIN INTERNATIONAL LIMITED
- BelgiumBrineura 150 mgBioMarin International
- NetherlandsBrineura 150 mg oplossing voor infusieBioMarin International Limited
- FranceBRINEURA 150 mg, solution pour perfusionBIOMARIN INTERNATIONAL LIMITED (IRLANDE)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/60fc635c-7b7a-437f-bcbe-0304a3b1b41b GET /v1/drugs/60fc635c-7b7a-437f-bcbe-0304a3b1b41b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "infusionsvæske, opløsning",
"source": "dkma",
"strength": "150 mg",
"auth_role": "MOD",
"dk_drugid": "28105798716",
"substance": "Cerliponase alfa",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42887"
}See everything about cerliponase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.